Ball & CO Wealth Management Inc. Abb Vie Inc. Transaction History
Ball & CO Wealth Management Inc.
- $93.9 Million
- Q2 2025
A detailed history of Ball & CO Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ball & CO Wealth Management Inc. holds 2,253 shares of ABBV stock, worth $447,535. This represents 0.45% of its overall portfolio holdings.
Number of Shares
2,253
Previous 2,233
0.9%
Holding current value
$447,535
Previous $467,000
10.49%
% of portfolio
0.45%
Previous 0.5%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,249Shares Held
1.27BCall Options Held
16.5MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA177MShares$35.2 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.17 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $351B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...